260 related articles for article (PubMed ID: 31569415)
1. Curcumin Mitigates Immune-Induced Epithelial Barrier Dysfunction by
Lobo de Sá FD; Butkevych E; Nattramilarasu PK; Fromm A; Mousavi S; Moos V; Golz JC; Stingl K; Kittler S; Seinige D; Kehrenberg C; Heimesaat MM; Bereswill S; Schulzke JD; Bücker R
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31569415
[No Abstract] [Full Text] [Related]
2. Vitamin D Reverses Disruption of Gut Epithelial Barrier Function Caused by
Lobo de Sá FD; Backert S; Nattramilarasu PK; Mousavi S; Sandle GI; Bereswill S; Heimesaat MM; Schulzke JD; Bücker R
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445577
[TBL] [Abstract][Full Text] [Related]
3. Contribution of
Butkevych E; Lobo de Sá FD; Nattramilarasu PK; Bücker R
Front Microbiol; 2020; 11():344. PubMed ID: 32210941
[No Abstract] [Full Text] [Related]
4. Immune-Mediated Aggravation of the
Nattramilarasu PK; Lobo de Sá FD; Schulzke JD; Bücker R
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33669494
[No Abstract] [Full Text] [Related]
5. Campylobacter fetus impairs barrier function in HT-29/B6 cells through focal tight junction alterations and leaks.
Bücker R; Krug SM; Fromm A; Nielsen HL; Fromm M; Nielsen H; Schulzke JD
Ann N Y Acad Sci; 2017 Oct; 1405(1):189-201. PubMed ID: 28662272
[TBL] [Abstract][Full Text] [Related]
6. Campylobacter jejuni impairs sodium transport and epithelial barrier function via cytokine release in human colon.
Bücker R; Krug SM; Moos V; Bojarski C; Schweiger MR; Kerick M; Fromm A; Janßen S; Fromm M; Hering NA; Siegmund B; Schneider T; Barmeyer C; Schulzke JD
Mucosal Immunol; 2018 Mar; 11(2):474-485. PubMed ID: 28766554
[TBL] [Abstract][Full Text] [Related]
7. Disruption of tight junctions and induction of proinflammatory cytokine responses in colonic epithelial cells by Campylobacter jejuni.
Chen ML; Ge Z; Fox JG; Schauer DB
Infect Immun; 2006 Dec; 74(12):6581-9. PubMed ID: 17015453
[TBL] [Abstract][Full Text] [Related]
8. Oral curcumin ameliorates acute murine campylobacteriosis.
Heimesaat MM; Mousavi S; Lobo de Sá FD; Peh E; Schulzke JD; Bücker R; Kittler S; Bereswill S
Front Immunol; 2024; 15():1363457. PubMed ID: 38855111
[TBL] [Abstract][Full Text] [Related]
9. Cellular Tight Junctions Prevent Effective
Hatayama S; Shimohata T; Amano S; Kido J; Nguyen AQ; Sato Y; Kanda Y; Tentaku A; Fukushima S; Nakahashi M; Uebanso T; Mawatari K; Takahashi A
Front Cell Infect Microbiol; 2018; 8():15. PubMed ID: 29441328
[No Abstract] [Full Text] [Related]
10. Epidermal growth factor inhibits Campylobacter jejuni-induced claudin-4 disruption, loss of epithelial barrier function, and Escherichia coli translocation.
Lamb-Rosteski JM; Kalischuk LD; Inglis GD; Buret AG
Infect Immun; 2008 Aug; 76(8):3390-8. PubMed ID: 18490463
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-18 Mediates Immune Responses to Campylobacter jejuni Infection in Gnotobiotic Mice.
Bereswill S; Alutis ME; Grundmann U; Fischer A; Göbel UB; Heimesaat MM
PLoS One; 2016; 11(6):e0158020. PubMed ID: 27322540
[TBL] [Abstract][Full Text] [Related]
12. Campylobacter jejuni disrupts protective Toll-like receptor 9 signaling in colonic epithelial cells and increases the severity of dextran sulfate sodium-induced colitis in mice.
O'Hara JR; Feener TD; Fischer CD; Buret AG
Infect Immun; 2012 Apr; 80(4):1563-71. PubMed ID: 22311925
[TBL] [Abstract][Full Text] [Related]
13. A porcine ligated loop model reveals new insight into the host immune response against
Negretti NM; Ye Y; Malavasi LM; Pokharel SM; Huynh S; Noh S; Klima CL; Gourley CR; Ragle CA; Bose S; Looft T; Parker CT; Clair G; Adkins JN; Konkel ME
Gut Microbes; 2020 Nov; 12(1):1-25. PubMed ID: 32887530
[TBL] [Abstract][Full Text] [Related]
14. Delineation of the innate and adaptive T-cell immune outcome in the human host in response to Campylobacter jejuni infection.
Edwards LA; Nistala K; Mills DC; Stephenson HN; Zilbauer M; Wren BW; Dorrell N; Lindley KJ; Wedderburn LR; Bajaj-Elliott M
PLoS One; 2010 Nov; 5(11):e15398. PubMed ID: 21085698
[TBL] [Abstract][Full Text] [Related]
15. The Human Milk Oligosaccharide 2'-Fucosyllactose Quenches Campylobacter jejuni-Induced Inflammation in Human Epithelial Cells HEp-2 and HT-29 and in Mouse Intestinal Mucosa.
Yu ZT; Nanthakumar NN; Newburg DS
J Nutr; 2016 Oct; 146(10):1980-1990. PubMed ID: 27629573
[TBL] [Abstract][Full Text] [Related]
16. Resveratrol Prevents
Lobo de Sá FD; Heimesaat MM; Bereswill S; Nattramilarasu PK; Schulzke JD; Bücker R
Front Pharmacol; 2021; 12():640572. PubMed ID: 33935732
[No Abstract] [Full Text] [Related]
17. Absence of Nucleotide-Oligomerization-Domain-2 Is Associated with Less Distinct Disease in
Heimesaat MM; Grundmann U; Alutis ME; Fischer A; Bereswill S
Front Cell Infect Microbiol; 2017; 7():322. PubMed ID: 28752081
[TBL] [Abstract][Full Text] [Related]
18. Campylobacter jejuni induces an anti-inflammatory response in human intestinal epithelial cells through activation of phosphatidylinositol 3-kinase/Akt pathway.
Li YP; Vegge CS; Brøndsted L; Madsen M; Ingmer H; Bang DD
Vet Microbiol; 2011 Feb; 148(1):75-83. PubMed ID: 20863633
[TBL] [Abstract][Full Text] [Related]
19. The role of serine protease HtrA in acute ulcerative enterocolitis and extra-intestinal immune responses during Campylobacter jejuni infection of gnotobiotic IL-10 deficient mice.
Heimesaat MM; Alutis M; Grundmann U; Fischer A; Tegtmeyer N; Böhm M; Kühl AA; Göbel UB; Backert S; Bereswill S
Front Cell Infect Microbiol; 2014; 4():77. PubMed ID: 24959425
[TBL] [Abstract][Full Text] [Related]
20. Campylobacter jejuni induces acute enterocolitis in gnotobiotic IL-10-/- mice via Toll-like-receptor-2 and -4 signaling.
Haag LM; Fischer A; Otto B; Plickert R; Kühl AA; Göbel UB; Bereswill S; Heimesaat MM
PLoS One; 2012; 7(7):e40761. PubMed ID: 22808254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
